ImmPACT Bio to Present New Preclinical Data for CD19/CD20 Bispecific CAR-T Cell Therapy in Multiple Sclerosis

/PRNewswire/ -- ImmPACT Bio USA Inc. (ImmPACT Bio), a clinical-stage biopharmaceutical company developing a new generation of cellular therapies that have the...

Related Keywords

Tennessee ,United States ,Ethan Bendavid ,Sumant Ramachandra ,Music City Center ,Immpact Bio United States Inc ,Consortium Of Multiple Sclerosis Centers ,Multiple Sclerosis Centers ,Annual Meeting ,Cell Therapy ,Exhibit Hall ,